Annual CFO
-$18.86 M
-$3.24 M-20.74%
December 31, 2023
Summary
- As of February 12, 2025, NVNO annual cash flow from operations is -$18.86 million, with the most recent change of -$3.24 million (-20.74%) on December 31, 2023.
- During the last 3 years, NVNO annual CFO has fallen by -$11.18 million (-145.64%).
- NVNO annual CFO is now -833.80% below its all-time high of -$2.02 million, reached on December 31, 2015.
Performance
NVNO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$4.28 M
-$368.00 K-9.42%
September 30, 2024
Summary
- As of February 12, 2025, NVNO quarterly cash flow from operations is -$4.28 million, with the most recent change of -$368.00 thousand (-9.42%) on September 30, 2024.
- Over the past year, NVNO quarterly CFO has increased by +$697.00 thousand (+14.02%).
- NVNO quarterly CFO is now -604.10% below its all-time high of -$607.30 thousand, reached on March 31, 2017.
Performance
NVNO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$16.71 M
-$63.00 K-0.38%
September 30, 2024
Summary
- As of February 12, 2025, NVNO TTM cash flow from operations is -$16.71 million, with the most recent change of -$63.00 thousand (-0.38%) on September 30, 2024.
- Over the past year, NVNO TTM CFO has increased by +$2.15 million (+11.41%).
- NVNO TTM CFO is now -2650.86% below its all-time high of -$607.30 thousand, reached on March 31, 2017.
Performance
NVNO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NVNO Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -20.7% | +14.0% | +11.4% |
3 y3 years | -145.6% | +16.3% | +4.0% |
5 y5 years | -196.7% | +16.3% | +4.0% |
NVNO Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -59.2% | at low | -37.9% | +16.3% | -47.5% | +11.4% |
5 y | 5-year | -219.8% | at low | -271.1% | +16.3% | -206.8% | +11.4% |
alltime | all time | -833.8% | at low | -604.1% | +16.3% | -2650.9% | +11.4% |
EnVVeno Medical Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$4.28 M(+9.4%) | -$16.71 M(+0.4%) |
Jun 2024 | - | -$3.91 M(+10.1%) | -$16.64 M(-3.8%) |
Mar 2024 | - | -$3.55 M(-28.6%) | -$17.30 M(-8.3%) |
Dec 2023 | -$18.86 M(+20.7%) | -$4.97 M(+18.0%) | -$18.86 M(+6.3%) |
Sep 2023 | - | -$4.21 M(-7.7%) | -$17.74 M(-1.5%) |
Jun 2023 | - | -$4.56 M(-10.7%) | -$18.01 M(+3.5%) |
Mar 2023 | - | -$5.11 M(+32.5%) | -$17.41 M(+11.4%) |
Dec 2022 | -$15.62 M(+31.8%) | -$3.86 M(-14.0%) | -$15.62 M(+5.1%) |
Sep 2022 | - | -$4.48 M(+13.2%) | -$14.87 M(+17.8%) |
Jun 2022 | - | -$3.96 M(+19.2%) | -$12.62 M(+11.4%) |
Mar 2022 | - | -$3.32 M(+7.1%) | -$11.33 M(-4.4%) |
Dec 2021 | -$11.85 M(+54.3%) | -$3.10 M(+38.9%) | -$11.85 M(+4.3%) |
Sep 2021 | - | -$2.23 M(-16.4%) | -$11.36 M(-3.1%) |
Jun 2021 | - | -$2.67 M(-30.5%) | -$11.72 M(+13.0%) |
Mar 2021 | - | -$3.84 M(+47.0%) | -$10.37 M(+35.0%) |
Dec 2020 | -$7.68 M | -$2.61 M(+0.9%) | -$7.68 M(+14.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$2.59 M(+96.4%) | -$6.69 M(+22.8%) |
Jun 2020 | - | -$1.32 M(+14.5%) | -$5.45 M(-2.0%) |
Mar 2020 | - | -$1.15 M(-29.0%) | -$5.55 M(-5.8%) |
Dec 2019 | -$5.90 M(-7.2%) | -$1.62 M(+20.2%) | -$5.90 M(+3.1%) |
Sep 2019 | - | -$1.35 M(-5.6%) | -$5.72 M(-6.5%) |
Jun 2019 | - | -$1.43 M(-4.3%) | -$6.11 M(-1.8%) |
Mar 2019 | - | -$1.49 M(+3.4%) | -$6.22 M(-2.1%) |
Dec 2018 | -$6.36 M(+51.2%) | -$1.44 M(-17.2%) | -$6.36 M(+2.8%) |
Sep 2018 | - | -$1.74 M(+13.2%) | -$6.18 M(+9.5%) |
Jun 2018 | - | -$1.54 M(-5.2%) | -$5.65 M(+8.2%) |
Mar 2018 | - | -$1.63 M(+27.9%) | -$5.22 M(+24.2%) |
Dec 2017 | -$4.20 M(+23.0%) | -$1.27 M(+5.1%) | -$4.20 M(+43.4%) |
Sep 2017 | - | -$1.21 M(+8.5%) | -$2.93 M(+70.2%) |
Jun 2017 | - | -$1.11 M(+83.5%) | -$1.72 M(+183.5%) |
Mar 2017 | - | -$607.30 K | -$607.30 K |
Dec 2016 | -$3.42 M(+69.2%) | - | - |
Dec 2015 | -$2.02 M | - | - |
FAQ
- What is enVVeno Medical annual cash flow from operations?
- What is the all time high annual CFO for enVVeno Medical?
- What is enVVeno Medical annual CFO year-on-year change?
- What is enVVeno Medical quarterly cash flow from operations?
- What is the all time high quarterly CFO for enVVeno Medical?
- What is enVVeno Medical quarterly CFO year-on-year change?
- What is enVVeno Medical TTM cash flow from operations?
- What is the all time high TTM CFO for enVVeno Medical?
- What is enVVeno Medical TTM CFO year-on-year change?
What is enVVeno Medical annual cash flow from operations?
The current annual CFO of NVNO is -$18.86 M
What is the all time high annual CFO for enVVeno Medical?
enVVeno Medical all-time high annual cash flow from operations is -$2.02 M
What is enVVeno Medical annual CFO year-on-year change?
Over the past year, NVNO annual cash flow from operations has changed by -$3.24 M (-20.74%)
What is enVVeno Medical quarterly cash flow from operations?
The current quarterly CFO of NVNO is -$4.28 M
What is the all time high quarterly CFO for enVVeno Medical?
enVVeno Medical all-time high quarterly cash flow from operations is -$607.30 K
What is enVVeno Medical quarterly CFO year-on-year change?
Over the past year, NVNO quarterly cash flow from operations has changed by +$697.00 K (+14.02%)
What is enVVeno Medical TTM cash flow from operations?
The current TTM CFO of NVNO is -$16.71 M
What is the all time high TTM CFO for enVVeno Medical?
enVVeno Medical all-time high TTM cash flow from operations is -$607.30 K
What is enVVeno Medical TTM CFO year-on-year change?
Over the past year, NVNO TTM cash flow from operations has changed by +$2.15 M (+11.41%)